Abstract
Introduction: Celiac disease (CD)-related antibody positivity in children with type 1 diabetes (T1D) may fluctuate and become negative spontaneously. There are uncertainties about the optimal tissue transglutaminase IgA (tTG-IgA) titre and timing of endoscopy in the diagnosis of CD, and this study aimed to contribute to the debate on the tTG-IgA threshold titre for endoscopy decisions in children with T1D. Methods: The data of 991 children with T1D who had undergone serologic evaluation for CD were analysed retrospectively. The tTG-IgA positivity rate and the upper limit of normal (ULN) tTG-IgA positivity were assessed. Participants were grouped according to the frequency, course, and test results of tTG-IgA tests. Those with and without histopathologic diagnosis of CD by endoscopic biopsy were compared in terms of tTG-IgA screening time and tTG-IgA predictive values. Results: In 10.2% (n:101) of all cases, tTG-IgA antibody was positive and endoscopic biopsy was performed in 68.3% (n:69) of these cases. Of all cases, 4.3% (n:43) were diagnosed with CD by endoscopic biopsy. A tTG-IgA titre of 7×ULN and above was found to be the best predictive value for the diagnosis of CD with 79.1% sensitivity, 80.8% specificity 87.2% positive predictive value, and 70% negative predictive value. Conclusions: Approximately 10% of antibody positive cases showed fluctuating and low-titre positivity, and no CD was detected by endoscopic biopsy in the group with fluctuating antibody course. The results of our study suggest that endoscopy in children with tTG-IgA levels 7×ULN or above may prevent both false-positive results and missed cases.
Journal Section:
Endoscopy and Imaging
References
1.
Knip
M
. Similarities and dissimilarities between type 1 diabetes and coeliac disease
. Acta Paediatr
. 2023
;112
(10
):2030
–1
. 2.
Craig
ME
, Prinz
N
, Boyle
CT
, Campbell
FM
, Jones
TW
, Hofer
SE
, et al. Prevalence of celiac disease in 52,721 youth with type 1 diabetes: international comparison across three continents
. Diabetes Care
. 2017
;40
(8
):1034
–40
. 3.
Pham-Short
ADK
, Donaghue
KC
, Ambler
G
, Chan
AK
, Craig
ME
. Coeliac disease in type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration
. Diabet Med
. 2012
;29
(9
):e286
–9
. 4.
Pham-Short
A
, Donaghue
KC
, Ambler
G
, Phelan
H
, Twigg
S
, Craig
ME
. Screening for celiac disease in type 1 diabetes: a systematic review
. Pediatrics
. 2015
;136
(1
):e170
–6
. 5.
Taczanowska
A
, Schwandt
A
, Amed
S
, Tóth-Heyn
P
, Kanaka-Gantenbein
C
, Volsky
SK
, et al. Celiac disease in children with type 1 diabetes varies around the world: an international, cross-sectional study of 57 375 patients from the SWEET registry
. J Diabetes
. 2021
;13
(6
):448
–57
. 6.
Fröhlich-Reiterer
E
, Elbarbary
NS
, Simmons
K
, Buckingham
B
, Humayun
KN
, Johannsen
J
, et al. ISPAD Clinical Practice Consensus Guidelines 2022: other complications and associated conditions in children and adolescents with type 1 diabetes
. Pediatr Diabetes
. 2022
;23
(8
):1451
–67
. 7.
Gülcü Taşkın
D
, Ata
A
. The screening of celiac serology in pediatric patients diagnosed with type 1 diabetes mellitus
. Turk J Gastroenterol
. 2023
;34
(3
):293
–7
. 8.
Unal
E
, Demiral
M
, Baysal
B
, Ağın
M
, Devecioğlu
EG
, Demirbilek
H
, et al. Frequency of celiac disease and spontaneous normalization rate of celiac serology in children and adolescent patients with type 1 diabetes
. J Clin Res Pediatr Endocrinol
. 2021
;13
(1
):72
–9
. 9.
Sari
S
, Yeşilkaya
E
, Eğritaş
O
, Bideci
A
, Cinaz
P
, Dalgiç
B
. Prevalence of Celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives
. Turk J Gastroenterol
. 2010
;21
(1
):34
–8
. 10.
Simsek
DG
, Aycan
Z
, Özen
S
, Cetinkaya
S
, Kara
C
, Abalı
S
, et al. Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study
. J Clin Res Pediatr Endocrinol
. 2013
;5
(1
):20
–6
. 11.
Husby
S
, Koletzko
S
, Korponay-Szabó
I
, Kurppa
K
, Mearin
ML
, Ribes-Koninckx
C
, et al. European society paediatric Gastroenterology, Hepatology and nutrition guidelines for diagnosing coeliac disease 2020
. J Pediatr Gastroenterol Nutr
. 2020
;70
(1
):141
–56
. 12.
Castellaneta
S
, Piccinno
E
, Oliva
M
, Cristofori
F
, Vendemiale
M
, Ortolani
F
, et al. High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study
. Diabetes Care
. 2015
;38
(5
):760
–6
. 13.
Hatun
Ş
, Dalgıç
B
, Gökşen
D
, Aydoğdu
S
, Savaş Erdeve
Ş
, Kuloğu
Z
, et al. Recommendations for clinical decision-making in children with type 1 diabetes and celiac disease: type 1 diabetes and celiac disease joint working group report
. J Clin Res Pediatr Endocrinol
. 2022
;14
(1
):1
–9
. 14.
Wessels
M
, Velthuis
A
, van Lochem
E
, Duijndam
E
, Hoorweg-Nijman
G
, de Kruijff
I
, et al. Raising the cut-off level of anti-tissue transglutaminase antibodies to detect celiac disease reduces the number of small bowel biopsies in children with type 1 diabetes: a retrospective study
. J Pediatr
. 2020
;223
:87
–92.e1
. 15.
Kamrath
C
, Tittel
SR
, Dunstheimer
D
, Fröhlich-Reiterer
E
, Freff
M
, Böttcher
C
, et al. Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes
. Diabetologia
. 2022
;65
(7
):1108
–18
. 16.
Marsh
MN
. Mucosal pathology in gluten sensitivity
. In: Marsh
MN
, editor. Coeliac disease
. Oxford
: Blackwell Scientific Publications
; 1992
. p. 136
.17.
Stahl
M
, Koletzko
S
, Andrén Aronsson
C
, Lindfors
K
; TEDDY Study Group
, Liu
E
, Agardh
D
, et al. Coeliac disease: what can we learn from prospective studies about disease risk
. Lancet Child Adolesc Health
. 2024
;8
(1
):63
–74
. 18.
Guandalini
S
. The when, why and whom to biopsy of type 1 diabetes mellitus children with positive anti-tissue transglutaminase serology
. Saudi J Gastroenterol
. 2023
;29
(5
):257
–8
. 19.
O’Donnell
HK
, Rasmussen
CG
, Dong
F
, Simmons
KM
; ASK Study Group
; Steck
AK
, Frohnert
BI
, et al. Anxiety and risk perception in parents of children identified by population screening as high risk for type 1 diabetes
. Diabetes Care
. 2023
;46
(12
):2155
–61
. 20.
Slae
M
, Romem
A
, Edri
S
, Toker
O
, Wilschanski
M
, Strich
D
. Celiac disease and celiac antibodies in DM1 patients: when are screening and biopsy recommended
. Dig Dis Sci
. 2019
;64
(2
):487
–92
. 21.
Hagopian
W
, Lee
HS
, Liu
E
, Rewers
M
; TEDDY Study Group
; She
JX
, Ziegler
AG
, et al. Co-Occurrence of type 1 diabetes and celiac disease autoimmunity
. Pediatrics
. 2017
;140
(5
):e20171305
. 22.
Goodwin
G
. Type 1 diabetes mellitus and celiac disease: distinct autoimmune disorders that share common pathogenic mechanisms
. Horm Res Paediatr
. 2019
;92
(5
):285
–92
. 23.
Li Voon Chong
JS
, Leong
KS
, Wallymahmed
M
, Sturgess
R
, MacFarlane
IA
. Is coeliac disease more prevalent in young adults with coexisting Type 1 diabetes mellitus and autoimmune thyroid disease compared with those with Type 1 diabetes mellitus alone
. Diabet Med
. 2002
;19
(4
):334
–7
. 24.
Waisbourd-Zinman
O
, Hojsak
I
, Rosenbach
Y
, Mozer-Glassberg
Y
, Shalitin
S
, Phillip
M
, et al. Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus
. Dig Dis Sci
. 2012
;57
(5
):1314
–20
. 25.
Krauthammer
A
, Guz-Mark
A
, Zevit
N
, Marderfeld
L
, Waisbourd-Zinman
O
, Silbermintz
A
, et al. Age-dependent trends in the celiac disease: a tertiary center experience
. J Pediatr Gastroenterol Nutr
. 2021
;72
(6
):894
–9
. 26.
Kurppa
K
, Laitinen
A
, Agardh
D
. Coeliac disease in children with type 1 diabetes
. Lancet Child Adolesc Health
. 2018
;2
(2
):133
–43
. 27.
Agardh
D
, Lee
HS
, Kurppa
K
, Simell
V
; TEDDY Study Group
, Aronsson
CA
, Jörneus
O
, et al. Clinical features of celiac disease: a prospective birth cohort
. Pediatrics
. 2015
;135
(4
):627
–34
. 28.
Cerutti
F
, Bruno
G
, Chiarelli
F
, Lorini
R
, Meschi
F
, Sacchetti
C
. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes
. Diabetes Care
. 2004
;27
(6
):1294
–8
. 29.
Fröhlich-Reiterer
EE
, Kaspers
S
, Hofer
S
, Schober
E
, Kordonouri
O
, Pozza
SBD
, et al. Anthropometry, metabolic control, and follow-up in children and adolescents with type1 diabetes mellitus and biopsy-proven celiac disease
. J Pediatr
. 2011
;158
(4
):589
–93.e2
. 30.
Wilkes
M
, Graber
E
, Rapaport
R
. Screening for celiac disease in youth with type 1 diabetes: are current recommendations adequate
. J Diabetes
. 2021
;13
(6
):525
–6
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
